[Use of narcotic antagonists after analgesic anesthesia].
D000701:Analgesics, Opioid / Q000627:therapeutic use; D000758:Anesthesia / Q000379:methods*; D001575:Benzomorphans / Q000031:analogs & derivatives / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D006801:Humans; D009019:Morphinans / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D009294:Narcotics / Q000494:pharmacology; D010423:Pentazocine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D019966:Substance-Related Disorders / Q000209:etiology; D013993:Tilidine / Q000494:pharmacology
D000701:Analgesics, Opioid; D001575:Benzomorphans; D009019:Morphinans; D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D013993:Tilidine; D010423:Pentazocine
Utilisation des antimorphiniques après une anesthésie analgésique